7 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2026 | $2.4B | $225034 | 33.3% | 10.5% | 0.1% | 0.0% | — | $1.3B | $193M |
| 2024 | $2.0B | -$10929 | 31.4% | 6.9% | 0.0% | -0.0% | — | $1.3B | $84M |
| 2023 | $1.9B | -$134524 | 31.4% | 0.4% | 0.1% | -0.0% | — | $1.3B | $44M |
| 2022 | $1.8B | -$662M | 30.9% | -35.9% | 10491.8% | -38.7% | — | $1.3B | $19M |
| 2022 | $1.7B | -$117M | 32.3% | -2.2% | -18.4% | -5.0% | -$27M | $1.2B | $30M |
| 2021 | $1.5B | -$57M | 30.4% | -0.2% | -21.5% | -3.1% | $101M | $1.2B | $137M |
| 2019 | $1.4B | -$77M | 30.3% | 2.8% | -28.3% | — | -$25M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jul '26 | $670M | $40M | 32.6% | 11.9% | 14.0% | 1.9% | — | $1.3B | $97M |
| Apr '26 | $648M | $42M | 31.7% | 10.7% | 17.4% | 2.1% | — | $1.3B | $189M |
| Sep '25 | $622M | $14M | 32.6% | 8.6% | 153.1% | 0.8% | — | $1.3B | $146M |
| Jun '25 | $590M | $27M | 35.8% | 13.6% | -225.4% | 1.5% | — | $1.3B | $101M |
| Mar '25 | $559M | $5M | 32.8% | 9.3% | -5.2% | 0.3% | — | $1.3B | $71M |
| Dec '24 | $520M | $29M | 33.0% | 8.8% | -23.6% | 1.8% | — | $1.3B | $84M |
| Sep '24 | $509M | -$43M | 31.4% | 6.7% | 27.4% | -2.6% | — | $1.3B | $78M |
| Jun '24 | $505M | $14M | 31.3% | 7.4% | -11.7% | 0.8% | — | $1.3B | $48M |
| Mar '24 | $491M | -$11M | 29.7% | 4.7% | 8.2% | -0.7% | — | $1.3B | $43M |
| Dec '23 | $479M | -$26M | 31.0% | 6.1% | 19.9% | -1.6% | — | $1.3B | $44M |
| Sep '23 | $478M | -$102M | 30.8% | -16.0% | 96.9% | -6.2% | — | $1.3B | $48M |
| Jul '23 | $472M | $26M | 32.9% | 7.9% | -380.0% | 1.5% | — | $1.3B | $28M |
| Apr '23 | $466M | -$32M | 31.0% | 3.8% | 89.2% | -1.8% | — | $1.3B | $34M |
| Dec '22 | $451M | -$238M | 28.5% | -45.3% | 3768.3% | -13.9% | — | $1.3B | $19M |
| Oct '22 | $443M | $24M | 30.4% | 1.1% | 10.7% | 1.2% | $18M | $1.3B | $64M |
| Jul '22 | $443M | -$474M | 32.7% | -103.0% | -236.8% | -24.8% | -$22M | $1.2B | $17M |
| Apr '22 | $451M | $25M | 32.1% | 3.1% | 3.8% | 1.1% | -$13M | $1.2B | $17M |
| Jan '22 | $414M | -$126M | 30.0% | -27.3% | -19.8% | -5.4% | -$39M | $1.2B | $30M |
| Oct '21 | $411M | $2M | 34.0% | 4.5% | 0.3% | 0.1% | $32M | $838M | $122M |
| Jul '21 | $436M | $1M | 33.6% | 6.9% | 0.2% | 0.1% | $16M | $846M | $107M |
How the market has priced AVAH against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Aveanna Healthcare Holdings, Inc.'s revenue has grown 10.2% per year. These are computed facts, not advice.
As of FY2026, Aveanna Healthcare Holdings, Inc. reported $1.3B of total debt against $193M of cash; operating income covered interest expense 1.8×.
In FY2026, gross margin was 33.3%, operating margin 10.5%, and net margin 0.0%.
As of Sep '26, Aveanna Healthcare Holdings, Inc. traded at a price-to-earnings ratio of about 13227.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.